Dr. Loomba is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Gilman Drive
Uc303 Mc0063
La Jolla, CA 92093Phone+1 858-534-2230Fax+1 858-534-3338
Summary
- Dr. Rohit Loomba is a gastroenterologist in La Jolla, CA and is affiliated with UC San Diego Health. He received his medical degree from Armed Forces Medical College Pune and has been in practice 23 years. He also speaks multiple languages, including Hindi, Punjabi, and Urdu. He specializes in hepatology & liver transplantation and is experienced in general gastroenterology, hepatology, hepatic cirrhosis, transplant hepatology, and biliary tract disease. He is an internationally recognized thought leader in translational research and innovative clinical trial design in metabolic-dysfunction associated steatohepatitis (MASH) and non-invasive assessment of liver disease using advanced imaging modalities. . Dr. Loomba also serves on the Scientific Advisory Board of numerous biotechnology and large pharmaceutical companies and guides clinical drug development and biomarker discovery programs globally.
Dr. Loomba has been consistently listed among the top 1% of the globally highly cited scientists across all fields since 2019 by Web of Science. He is an elected member of the ASCI and the Association of American Physicians (AAP).
Education & Training
- University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2007 - 2009
- Duke University School of MedicineMHS, Clinical Research, 2005 - 2007
- Clinical Center at the National Institutes of HealthFellowship, Transplant Hepatology, 2004 - 2007
- St Luke's HospitalResidency, Internal Medicine, 2000 - 2003
- ArMed Forces Medical College PuneClass of 1999
Certifications & Licensure
- CA State Medical License 2007 - 2026
- MD State Medical License 2004 - 2010
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Inducted as an elected member Association of American Physicians (AAP), 2023
- Clarivate™ Highly Cited Researcher Across All Fields in Science Globally Web of Science, 2020
- Inducted as an elected member American Society of Clinical Investigation, 2019
- Join now to see all
Clinical Trials
- Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2 Start of enrollment: 2009 Dec 02
- Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis Start of enrollment: 2010 Feb 01
- Alpha-1 Antitrypsin Deficiency Adult Liver Study Start of enrollment: 2013 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 898 citationsA multisociety Delphi consensus statement on new fatty liver disease nomenclature.Mary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, Sven M Francque, Arun J Sanyal
Journal of Hepatology. 2023-12-01 - 159 citationsGlobal epidemiology of cirrhosis - aetiology, trends and predictions.Daniel Q Huang, Norah A Terrault, Frank Tacke, Lise Lotte Gluud, Marco Arrese
Nature Reviews. Gastroenterology & Hepatology. 2023-06-01 - 33 citationsNoninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease.Nobuharu Tamaki, Masayuki Kurosaki, Daniel Q Huang, Rohit Loomba
Hepatology Research. 2022-06-01
Journal Articles
- The Lancet Child & Adolescent HealthArun Sanyal, Stephen A Harrison, Edgar D Charles, Stephanie Noviello, Manal F Abdelmalek, Eric J Lawitz, Rohit Loomba, The Lancet
- Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic SteatohepatitisRohit Loomba, Ariel E Feldstein, The Journal of Immunology
- Author Correction: Inflammation-Induced IgA+ Cells Dismantle Anti-Liver Cancer ImmunityRohit Loomba, MD, Nature
- Join now to see all
Abstracts/Posters
- Treatment with selonsertib, an inhibitor of apoptosis signal regulating kinase 1, hepatic phospho-p38 expression and markers of hepatocellular apoptosis and necrosis i...Diehl A.M., French D, Xu R, Loomba R, Lawitz E, Freilich B, Shiffman M.L., Chalasani N, Hameed B, Caldwell S, Rinella M, Peach M, Huntzicker E, Turner S, Sullivan T, C..., EASL, 1/1/2017
- Improvement of hepatic fibrosis in patients with non-alcoholic steatohepatitis treated with selonsertib is associated with improvement of patient-reported outcomes (PROS)Younossi Z.M., Stepanova M, Goodman Z, Lawitz E, Charlton M, Loomba R, Hunt S., EASL, 1/1/2017
- Methylation signatures in blood show accelerated epigenetic aging in patients with non-alcoholic steatohepatitis compared to healthy controls.Loomba R, Gindin Y, Jiang Z, Lawitz E, Djedjos C.S., Caldwell S, Xu R, Gong D, Myers R.P., Subramanian G.M., Goodman Z, Charlton M, Afdhal N.H., A.M. Diehl A.M., EASL, 1/1/2017
- Join now to see all
Lectures
- Novel Imaging and Management of NASH1/1/2017
- Imaging assessment of NAFLDNorthwestern University, Chicago, IL - 1/1/2016
- Novel phenotyping and imaging advances in NAFLDLiver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, NIH) - 1/1/2016
- Join now to see all
Authored Content
- UCSD Presence at AASLD the Liver Meeting 2023October 2023
Press Mentions
- Novel Drug Effective Against MASH in Phase II TrialOctober 14th, 2024
- Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in the Lancet Gastroenterology & HepatologyOctober 11th, 2024
- Study Show Tirzepatide Beneficial for Resolution of MASH in Patients with MASH, FibrosisJune 14th, 2024
- Join now to see all
Professional Memberships
- American Association for the Study of Liver DiseasesMember
- Member
- Member
- The American Society of Clinical InvestigationMember
- American Association for the Advancement of ScienceMember
Other Languages
- Hindi, Punjabi, Urdu
External Links
- UCSD NAFLD Research Centerhttps://healthsciences.ucsd.edu/som/medicine/divisions/gastro/research/NAFLD/pages/default.aspx
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: